Search results
Results from the WOW.Com Content Network
Major depressive disorder (MDD) is the second leading cause of disability worldwide and a major contributor to the burden of suicide and ischemic heart disease, new data indicate.
Major depressive disorder (MDD) is a common, chronic, recurrent and debilitating psychiatric condition, leading to significant impairments in personal functional capacities, which also eventually ...
Today we will be discussing sexual dysfunction associated with major depressive disorder and antidepressant treatments. It is a pleasure for me to introduce our guest today.
Methods Systematic searches of PubMed and PsycINFO studies between January 1970 and August 2012 were performed to identify (C-)RCTs, in which MDD was a primary diagnosis in adult outpatients ...
Following last year's granting of breakthrough designation for psilocybin for treatment-resistant depression, the FDA has now extended it to a broader group of patients with major depressive disorder.
These included 26 studies of anxiety symptoms among 10,378 individuals with GERD, 30 that looked at depressive symptoms among 14,030 subjects with GERD, and four that reported the prevalence of ...
The US Food and Drug Administration has approved dextromethorphan-bupropion (Auvelity), the first for an NMDA receptor antagonist for the treatment of major depressive disorder in adults.
MDD is a disorder that is often highly manageable; psychotherapy and medications are effective for about 80% of people who seek treatment. Patients generally report experiencing significant ...
The disorder predicts impaired social and academic functioning. Depressed adolescents frequently grow up to be depressed adults, requiring more medical and psychiatric hospitalisations. [ 4 ]
In 2019, individuals in this age range had at least one mental disorder and 31 million had a substance use disorder — an average prevalence of 11.6% and 1.2%, respectively.